Natixis’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,000
Closed -$896K 1147
2025
Q4
$896K Sell
76,000
-12,322
-14% -$158K ﹤0.01% 744
2025
Q3
$1.4M Buy
+88,322
New +$1.28M 0.01% 624
2024
Q2
Sell
-18,764
Closed -$493K 1014
2024
Q1
$493K Buy
18,764
+49
+0.3% +$1.4K ﹤0.01% 636
2023
Q4
$590K Buy
+18,715
New +$508K ﹤0.01% 592
2023
Q2
Sell
-300
Closed -$8.98K 1035
2023
Q1
$8.98K Sell
300
-68,900
-100% -$2.27M ﹤0.01% 897
2022
Q4
$2.12M Buy
+69,200
New +$2.08M 0.01% 526
2020
Q4
Sell
-9,986
Closed -$209K 1042
2020
Q3
$209K Buy
+9,986
New +$193K ﹤0.01% 696
2020
Q1
Sell
-171,369
Closed -$3.02M 712
2019
Q4
$3.02M Buy
+171,369
New +$2.85M 0.02% 492
2019
Q3
Sell
-269,823
Closed -$6.48M 821
2019
Q2
$6.48M Buy
269,823
+262,664
+3,669% +$7.74M 0.05% 278
2019
Q1
$263K Buy
+7,159
New +$261K ﹤0.01% 737
2018
Q3
Sell
-433,652
Closed -$19.2M 836
2018
Q2
$19.2M Sell
433,652
-173,545
-29% -$8.63M 0.1% 190
2018
Q1
$29.6M Sell
607,197
-628,139
-51% -$31.4M 0.18% 130
2017
Q4
$61.8M Buy
1,235,336
+889,164
+257% +$46.6M 0.48% 54
2017
Q3
$17.5M Buy
346,172
+333,852
+2,710% +$15.7M 0.16% 137
2017
Q2
$468K Sell
12,320
-6,047
-33% -$239K 0.01% 536
2017
Q1
$708K Sell
18,367
-1,460
-7% -$43.9K 0.01% 460
2016
Q4
$438K Buy
+19,827
New +$407K ﹤0.01% 549

Other funds holding CC

Natixis's CC Position: Q1 2026 in Review

Natixis sold out of Chemours (CC) in Q1 2026, closing a stake of 76,000 shares — an estimated $896K sold.

Natixis first reported a position in CC in Q4 2016 and held it in 17 quarters. The position peaked at $61.8M in Q4 2017. 449 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Natixis reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
  • Natixis sold 76,000 Chemours shares in Q1 2026, an estimated $896K.
  • Natixis first reported a position in Chemours in Q4 2016 and held it in 17 quarters.
  • Natixis's Chemours position peaked at $61.8M in Q4 2017.
  • 449 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.